141 related articles for article (PubMed ID: 36463006)
1. Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy.
Hara H; Kawamoto T; Fukase N; Sawada R; Fujiwara S; Yahiro S; Miyamoto T; Terakawa T; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
Eur J Surg Oncol; 2023 May; 49(5):928-933. PubMed ID: 36463006
[TBL] [Abstract][Full Text] [Related]
2. What Factors Are Associated With Local Metastatic Lesion Progression After Intramedullary Nail Stabilization?
Arpornsuksant P; Morris CD; Forsberg JA; Levin AS
Clin Orthop Relat Res; 2022 May; 480(5):932-945. PubMed ID: 34962492
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
4. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of 168 Chinese patients after local surgery for bone metastases arising from advanced renal cell carcinoma.
Dong Y; Wang Z; Lu X; Wu Z; Zhang Z; Yu Y; Peng F; Liu B; Wang L
Cancer; 2020 May; 126 Suppl 9():2079-2085. PubMed ID: 32293722
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
8. Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease.
Nooh A; Goulding K; Isler MH; Mottard S; Arteau A; Dion N; Turcotte R
Clin Orthop Relat Res; 2018 Mar; 476(3):535-545. PubMed ID: 29529637
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma.
Harada H; Shikama N; Wada H; Uchida N; Nozaki M; Hayakawa K; Yamada K; Nagakura H; Ogawa H; Miyazawa K; Katagiri H; Nakamura N
Jpn J Clin Oncol; 2021 Jan; 51(1):100-105. PubMed ID: 32869095
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
11. Patient survival after surgery for osseous metastases from renal cell carcinoma.
Lin PP; Mirza AN; Lewis VO; Cannon CP; Tu SM; Tannir NM; Yasko AW
J Bone Joint Surg Am; 2007 Aug; 89(8):1794-801. PubMed ID: 17671020
[TBL] [Abstract][Full Text] [Related]
12. Humeral metastasis of renal cancer: Surgical options and review of literature.
Casadei R; Drago G; Di Pressa F; Donati D
Orthop Traumatol Surg Res; 2018 Jun; 104(4):533-538. PubMed ID: 29654934
[TBL] [Abstract][Full Text] [Related]
13. Reoperation after surgery for bone metastasis of renal cell carcinoma.
Tsukamoto S; Aiba H; Zuccheri F; Mavrogenis AF; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
J Surg Oncol; 2024 Mar; 129(3):629-640. PubMed ID: 37929793
[TBL] [Abstract][Full Text] [Related]
14. Cabozantinib in the treatment of metastatic renal cell carcinoma - final data analysis from four oncology centers in the Czech Republic.
Richter I; Poprach A; Zemánková A; Büchler T; Bartoš J; Šámal V; Študentová H; Rozsypalová A; Dvořák J; Brom O; Melichar B
Klin Onkol; 2021; 34(5):392-400. PubMed ID: 34915708
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with improved survival following surgery for renal cell carcinoma spinal metastases.
Petteys RJ; Spitz SM; Goodwin CR; Abu-Bonsrah N; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL; Sciubba DM
Neurosurg Focus; 2016 Aug; 41(2):E13. PubMed ID: 27476837
[TBL] [Abstract][Full Text] [Related]
16. Bone metastases from renal cell carcinoma: patient survival after surgical treatment.
Fottner A; Szalantzy M; Wirthmann L; Stähler M; Baur-Melnyk A; Jansson V; Dürr HR
BMC Musculoskelet Disord; 2010 Jul; 11():145. PubMed ID: 20598157
[TBL] [Abstract][Full Text] [Related]
17. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.
Kalra S; Verma J; Atkinson BJ; Matin SF; Wood CG; Karam JA; Lin SH; Satcher RL; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
Clin Genitourin Cancer; 2017 Jun; 15(3):363-370. PubMed ID: 28216278
[TBL] [Abstract][Full Text] [Related]
19. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
20. Molecular-targeted Therapy and Surgery May Prolong Survival of Renal Cell Carcinoma Patients with Bone Metastasis: A Multi-institutional Retrospective Study in Japan.
Kitamura H; Takahashi A; Takei F; Hotta H; Miyao N; Shindo T; Igarashi M; Tachiki H; Kunishima Y; Muranaka T; Shigyo M; Ikehata Y; Masumori N;
Anticancer Res; 2016 Oct; 36(10):5531-5536. PubMed ID: 27798926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
